Sunday 25 February 2018
Contact US    |    Archive
foxbusiness
6 months ago

5 Things Regeneron s CEO Said as the Biotech Stock Sank

Regeneron stock dropped on Monday after concerns were raised with clinical results for Dupixent. Here s what the biotech s CEO had to say.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.

World of Photos

- wn.com
Hashtags:   

Things

 | 

Regeneron

 | 

CEO

 | 

Said

 | 

the

 | 

Biotech

 | 

Stock

 | 

Sank

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA